Xiaoying Qi

Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma

Hong Chang, Young Trieu, Xiaoying Qi et al. · Leukemia Research · 2006 · 89 citations

Medicine, Hematology, Pharmacotherapy +15

Multiple myeloma patients with <i>CKS1B</i> gene amplification have a shorter progression‐free survival post‐autologous stem cell transplantation

Hong Chang, Xiaoying Qi, Young Trieu et al. · British Journal of Haematology · 2006 · 87 citations

Medicine, Hematology, Oncology +15

1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma

Hong Chang, Xiaoying Qi, Annie Jiang et al. · Bone Marrow Transplantation · 2009 · 82 citations

Medicine, Cancer Biology, Oncology +12

Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia

Hong Chang, Xiaoying Qi, Joanna Yeung et al. · Leukemia Research · 2008 · 74 citations

Life Sciences, Genetics, Hematology +17

Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma

Hong Chang, Yi Ning, Xiaoying Qi et al. · British Journal of Haematology · 2007 · 51 citations

Life Sciences, Molecular Genetics, Oncology +17